A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use

Publication Date

2016

Journal Title

J Oncol Pharm Pract

Abstract

Pomalidomide is an analog of thalidomide with immunomodulatory, anti-angiogenic, and anti-neoplastic activity indicated for the treatment of multiple myeloma refractory to at least two prior therapies. The incidence for renal failure was

Volume Number

22

Issue Number

2

Pages

357-60

Document Type

Article

EPub Date

2015/01/17

Status

Faculty, Northwell Researcher

Facility

School of Medicine; Northwell Health

Primary Department

Nephrology

Additional Departments

Hospital Medicine; Hematology/Medical Oncology

PMID

25591868

DOI

10.1177/1078155214568581

For the public and Northwell Health campuses

Share

COinS